Psychopharmacological and antioxidant effects of hydroethanolic extract of Alpinia zerumbet leaves in mice

Krishnan, 2010, Linking molecules to mood: new insight into the biology of depression, Am J Psychiatry, 167, 1305, 10.1176/appi.ajp.2009.10030434 O’Donnell, 2011, Drug therapy of depression and anxiety disorders, 397 Papakostas, 2007, A meta-analysis of clinical trials comparing milnacipran, a serotonin-norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder, Eur Neuropsychopharmacol, 7, 32, 10.1016/j.euroneuro.2006.05.001 Papakostas, 2007, Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents, Biol Psychiatry, 62, 1217, 10.1016/j.biopsych.2007.03.027 Mendonça, 1991, Pharmacological and toxicological evaluation of Alpinia speciosa, Mem Oswaldo Cruz, 86, 93, 10.1590/S0074-02761991000600023 Laranja, 1991, Evaluation of acute administration of natural products with potential diuretic effects, in humans, Mem Inst Oswaldo Cruz, 86, 237, 10.1590/S0074-02761991000600053 Laranja, 1992, Avaliação de três plantas com potencial diurético, Rev Assoc Med Bras, 38, 13 Almeida, 1993 Lorenzi, 2002 Araújo, 2009, Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice, J Pharm Pharmacol, 61, 1521, 10.1211/jpp.61.11.0012 Murakami, 2009, Effects of the essential oil from leaves of Alpinia zerumbet on behavioral alterations in mice, Nat Prod Commun, 4, 129 Satou, 2010, Anxiolytic effect and tissue distribution of inhaled Alpinia zerumbet essential oil in mice, Nat Prod Commun, 5, 143 Devasagayam, 2004, Review-free radicals and antioxidants in human health: current status and future prospects, J Assoc Physicians India, 52, 794 Kotan, 2011, Effects of long-term antidepressant treatment on oxidative status major depressive disorder: a 24-week follow-up study, Prog Neuropsychopharmacol Biol Psychiatry, 35, 1284, 10.1016/j.pnpbp.2011.03.021 Steru, 1985, The tail suspension test: a new method for screening antidepressant in mice, Psychopharmacology, 85, 367, 10.1007/BF00428203 Li, 2001, Comparison of N2O and chlordiazepoxide-induced behaviors in the light/dark exploration test, Pharmacol Biochem Behav, 68, 789, 10.1016/S0091-3057(01)00487-7 Singleton, 1965, Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents, Am J Enol Vitic, 16, 144, 10.5344/ajev.1965.16.3.144 Kähkönen, 1999, Antioxidant activity of plant extracts containing phenolic compounds, J Agric Food Chem, 47, 3954, 10.1021/jf990146l Jay, 1975, Sur I`analyse qualitative dês aglycones flavonique dans une optique chimiotaxonomique, Phytochemistry, 14, 1605, 10.1016/0031-9422(75)85359-3 Benzie, 1996, The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay, Anal Biochem, 239, 70, 10.1006/abio.1996.0292 Brand-Williams, 1995, Use of a free radical method to evaluate antioxidant activity, Lebenson Wiss Technol, 28, 25, 10.1016/S0023-6438(95)80008-5 Aebi, 1984, Catalase in vitro, Meth Enzymol, 105, 121, 10.1016/S0076-6879(84)05016-3 Misra, 1972, The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase, J Biol Chem, 247, 5170, 10.1016/S0021-9258(19)45228-9 Ellman, 1959, Tissue sulfhydryl groups, Arch Biochem Biophys, 82, 70, 10.1016/0003-9861(59)90090-6 Ohkawa, 1979, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal Biochem, 95, 351, 10.1016/0003-2697(79)90738-3 Albarracin, 2012, Effects of natural antioxidants in neurodegenerative disease, Nutr Neurosci, 5, 1, 10.1179/1476830511Y.0000000028 Jurikova, 2011, Phenolic profile of edible honeysuckle berries (genus Lonicera) and their biological effects, Molecules, 17, 61, 10.3390/molecules17010061 Gul, 2011, Evaluation of Albemoschus moschatus extracts for antioxidant, free radical scavenging, antimicrobial and antiproliferative activities using in vitro assays, BMC Complement Altern Med, 11, 64, 10.1186/1472-6882-11-64 Rice-Evans, 1996, Structure-antioxidant activity relationships of flavonoids and phenolic acids, Free Radic Biol Med, 20, 933, 10.1016/0891-5849(95)02227-9 Halliwell, 2007, Biochemistry of oxidative stress, Biochem Soc Trans, 35, 1147, 10.1042/BST0351147 Bhaskar, 2009, In Vitro antioxidant property of Laticiferous plant species from Western Ghats Tamil Nadu, India, Int J Health Res, 2, 163 Ebrahimzadeh, 2009, Antioxidant activities of methanol extract of Sambucus ebulus L. flower, Pak J Biol Sci, 12, 447, 10.3923/pjbs.2009.447.450 Deutsch, 1998, Ascorbic acid oxidation by hydrogen peroxide, Anal Biochem, 255, 1, 10.1006/abio.1997.2293 Uttara, 2009, Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options, Curr Neuropharmacol, 7, 65, 10.2174/157015909787602823 Braugghler, 1986, The involvement of iron in lipid peroxidation. Importance of ferrous to ferric ratio in initiation, J Biol Chem, 261, 10282, 10.1016/S0021-9258(18)67521-0 Mohanakumar, 1994, Ferrous-citrate complex and degeneration: evidence for free-radical formation and lipid peroxidation, Ann N Y Acad Sci, 738, 392, 10.1111/j.1749-6632.1994.tb21828.x Halliwell, 1992, Reactive oxygen species and the central nervous system, J Neurochem, 59, 1609, 10.1111/j.1471-4159.1992.tb10990.x Brocardo, 2012, Anxiety- and depression-like behaviors are accompanied by an increase in oxidative stress in a rat model of fetal alcohol spectrum disorders: protective effects of voluntary physical exercise, Neuropharmacology, 62, 1607, 10.1016/j.neuropharm.2011.10.006 Sarandol, 2007, Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative antioxidative systems, Hum Psychopharmacol, 22, 67, 10.1002/hup.829